Thiazole-based inhibitors of scavenger receptor BI
Abstract:
This application describes compounds and methods that can inhibit Scavenger receptor class B, type I (SR-BI) activity, which compounds and methods can used, for example, to mediate high-density lipoprotein (HDL) lipid uptake and treat hepatitis C viral infections.
Public/Granted literature
Information query
Patent Agency Ranking
0/0